Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Tarlaci S – Venlafaxine and escitalopram are both effective in the prophylaxis of migraine headache without depression and anxiety. This effect was independent of mood disorder. Escitalopram should be the first choice because of its fewer side effects, but venlafaxine may be used if escitalopram is found to be insufficient.
Related Articles
Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Relevance Score: 79%
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 69%
CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09
Relevance Score: 68%
Controversies in migraine
Nurse Prescribing, 10/09/09
Relevance Score: 68%
New drugs for migraine
The Journal of Headache and Pain, 10/05/09
Relevance Score: 68%
Today in Emergency/Trauma...keeping you current
Receive free subspecialty "5-minute updates" via email
Superior cluneal nerve block for treatment of buttock abscesses in the emergency department
The Journal of Emergency Medicine, 11/20/09
The incidence of scaphoid fracture in a military population
Injury, 11/20/09
Ulnar artery distal cutaneous descending branch as free flap in hand reconstruction
Injury, 11/20/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Acute back pain: benefits and risks of current treatments
Current Medical Research and Opinion, 11/20/09
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
British Journal of Cancer, 11/20/09
Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis
Diabetes Care, 11/20/09
Article Search
Sponsor


See Latest Articles


